[1] Hui DS, Azhar EI, Madani TA, et al.The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan,China[J]. International Journal of Infectious Disease, 2020,91: 264-266. [2] Tan WJ, Zhao X, Ma XJ, et al.A novel coronavirus genome ident-ified in a cluster of pneumonia cases-Wuhan China 2019 - 2020[J].China CDC Weekly, 2020, 2(4): 61-62. [3] Cui J, Li F, Shi Z.Origin and evolution of pathogenic coronaviruses[J].Nature Reviews Microbiology,2019, 17(3): 181-192. [4] 中华人民共和国国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(试行第六版)[EB/OL].(2020-02-19)[2020-02-19].http://www.nhc.gov.cn/wjw/index.shtml. [5] 陈利娟,任丽娟. 我中心2011-2014年抗艾滋病毒药物应用分析[J]. 中国药房, 2017, 28(17): 2336-2339. [6] Bates DE, Herman RJ.Carbamazepine toxicity induced by lopinavir /ritonavir and nelfinavi[J]. The Annals of pharmacotherapy,2006, 40(6): 1190-1195. [7] Borrs-Blasco J, Bda A, Rosique-Robles D, et al.Hairloss induced by lopinavir /ritonavir[J]. Pharmacotherapy, 2007, 27(8):1215-1218. [8] Kim HS, Shin HS.Alopecia areata associated with abacavir therapy[J]. Infect Chemother, 2014, 46(2):103-105. [9] Greffrath WP, Plessis JM, Viljoen M, et al.Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavirinitiation[J]. South Afr J HIV Med, 2018, 19(1): 766. [10] Bandeira ACPCS, Elias DBD, Cavalcante MG.Antiretroviral changes during the first year of therapy[J]. Rev Assoc Med Bras,2017, 63(7):606-612. [11] Sunita G, Alecia GK, Boriss YL, et al.Brain Injury Caused by HIV Protease Inhibitors: role of Lipodystrophy and Insulin Resistance[J].Antiviral Res, 2012, 95(1):19-29. [12] Chu CM, Cheng VCC, Hung IFN, et al.Role of lopinavir /ritonavir in the treatment of SARS:initial virological and clinical findings[J]. Thorax, 2004, 59(3): 252-256. [13] Chen N, Zhou M, Dong X, et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan,China: a descriptive study[J]. The Lancet, 2020,395(10223): 507-513. [14] 江华,邓洪飞,王宇,等. 洛匹那韦利托那韦(LPV/r)用于2019新型冠状病毒肺炎的治疗可能性:基于既往冠状病毒肺炎研究的快速系统评价[J]. 中华急诊医学杂志, 2020, 29(2):182-185. [15] 靳英辉,蔡林,程真顺,等. 新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(标准版)[J]. 解放军医学杂志,2020, 45(1): 1-20. |